Advertisement

Vaccine Design pp 249-276 | Cite as

Structure and Properties of Aluminum-Containing Adjuvants

  • Stanley L. Hem
  • Joe L. White
Part of the Pharmaceutical Biotechnology book series (PBIO, volume 6)

Abstract

The use of aluminum-containing adjuvants originated in 1926 with the observations of Glenny et al. (1926) that an alum-precipitated diphtheria vaccine had greater antigenic properties than the standard diphtheria vaccine. Other aluminum hydroxide gels used in the preparation of vaccines were shown by the early X-ray diffraction and electron microscopy studies of Souza Santos et al. (1958) to consist of crystalline phases ranging from poorly ordered boehmite (aluminum oxyhydroxide, A100H) to well-crystallized gibbsite and bayerite [aluminum hydroxide polymorphs, Al(OH)3]. Aluminum hydroxide gels containing phosphate were also developed as adjuvants. Although aluminum compounds have a long history of use as adjuvants, inconsistent antibody production has been a recurrent problem (Warren and Chedid, 1988). The adjuvant action of aluminum hydroxide has been reviewed by Aprile and Wardlaw (1966), Edelman (1980), Warren et al. (1986), and Nicklas (1992). Although the mechanism of adjuvant action of aluminum hydroxide and related phases is not fully understood, it is likely that surface area, surface charge, and morphology of the aluminum hydroxide are important factors (Hem and White, 1984).

Keywords

Adsorptive Capacity Aluminum Hydroxide Sulfate Anion Phosphate Anion Amorphous Aluminum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Al-Shakhshir, R. H., Lee, A. L., White, J. L., and Hem, S. L., 1995a, Interactions in model vaccines composed of mixtures of aluminum-containing adjuvants, J. Colloid Interface Sci. 169:197–203.CrossRefGoogle Scholar
  2. Al-Shakhshir, R. H., Regnier, F. E., White, J. L., and Hem, S. L., 1995b, Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminum-containing adjuvants, Vaccine 13:41–44.PubMedCrossRefGoogle Scholar
  3. Al-Shakhshir, R., Regnier, F., White, J. L., and Hem, S. L., 1994, Effect of protein adsorption on the surface charge characteristics of aluminum-containing adjuvants, Vaccine 12:472–474.PubMedCrossRefGoogle Scholar
  4. Aprile, M. A., and Wardlaw, A. C., 1966, Aluminum compounds as adjuvants for vaccines and toxoids in man: A review, Can. J. Public Health 57:343–354.PubMedGoogle Scholar
  5. Bleam, W. F., Pfeffer, P. E., Goldberg, S., Taylor, R. W., and Dudley, R., 1991, A 31P solid-state nuclear magnetic resonance study of phosphate adsorption at the boehmite/aqueous solution interface, Langmuir 7:1703–1712.CrossRefGoogle Scholar
  6. Callahan, P. M., Shorter, A. L., and Hem, S. L., 1991, The importance of surface charge in the optimization of antigen-adjuvant interactions, Pharm. Res. 8:851–858.PubMedCrossRefGoogle Scholar
  7. Cheung, T. T. P., Willcox, K. W., McDaniel, M. P., and Johnson, M. M., 1986, The structure of coprecipitated alumino-phosphate catalyst supports, J. Catal. 10:10–20.CrossRefGoogle Scholar
  8. Edelman, R., 1980, Vaccine adjuvants, Rev. Infect. Dis. 2:370–383.PubMedCrossRefGoogle Scholar
  9. Fripiat, J. J., Bosmans, H., and Rouxhet, P. G., 1967, Proton mobility in solids. I. Hydrogenic vibration modes and proton delocalization in boehmite, J. Phys. Chem. 71:1097–1112.CrossRefGoogle Scholar
  10. Glenny, A. T., Pope, C. G., Waddington, H., and Wallace, U., 1926, The antigenic value of toxoid precipitated by potassium alum, J. Pathol. Bacteriol. 29:31–40.CrossRefGoogle Scholar
  11. Gooding, D. L., Schmuck, M. N., and Gooding, K. M., 1984, Analysis of proteins with new, mildly hydrophobic high performance liquid chromatography packing materials, J. Chromatogr. 296:107–114.CrossRefGoogle Scholar
  12. Hem, S. L., and White, J. L., 1984, Characterization of aluminum hydroxide for use as an adjuvant in parenteral vaccines, J. Parenteral Sci. Tech. 38:2–10.Google Scholar
  13. Hsu, P. H., 1979, Effect of phosphate and silicate on the crystallization of gibbsite from OH-A1 solutions, Soil Sci. 127:219–226.CrossRefGoogle Scholar
  14. Hsu, P. H., 1989, Aluminum hydroxides and oxyhydroxides in: Minerals in Soil Environments, 2nd ed. (J. B. Dixon and S. B. Weed, eds.), Soil Science Society of America, Madison, WI, pp. 331–378.Google Scholar
  15. Imoto, T., Johnson, L. N., North, A. G, Phillips, D. C., and Rupley, J. A., 1972, Vertebrate lysozymes, in: The Enzymes, Vol. 7 (P. D. Boyer, ed.), Academic Press, New York, pp. 665–868.Google Scholar
  16. Liu, J. C., Feldkamp, J. R., White, J. L., and Hem, S. L., 1984, Adsorption of phosphate by aluminum hydroxycarbonate, J. Pharm. Sci. 73:1355–1358.PubMedCrossRefGoogle Scholar
  17. MeSweeney, G. W., 1988, Fluid and electrolyte therapy and acid-base balance, in: Clinical Pharmacy and Therapeutics (E. T. Herfmdal, D. R. Gourley, and L. L. Hart, eds.), Williams & Wilkins, Baltimore, p. 2.Google Scholar
  18. Masood, H., White, J. L., and Hem, S. L., 1994, Relationship between protein adsorptive capacity and the X-ray diffraction pattern of aluminum hydroxide adjuvants, Vaccine 12:187–189.PubMedCrossRefGoogle Scholar
  19. Nail, S. L., White, J. L., and Hem, S. L., 1976a, Structure of aluminum hydroxide gel I: Initial precipitate, J. Pharm. Sci. 65:1188–1191.PubMedCrossRefGoogle Scholar
  20. Nail, S. L., White, J. L., and Hem, S. L., 1976b, Structure of aluminum hydroxide gel II: Aging mechanism, J. Pharm. Sci. 65:1192–1195.PubMedCrossRefGoogle Scholar
  21. Nicklas, W., 1992, Aluminum salts, Res. Immunol. 143:489–494.PubMedCrossRefGoogle Scholar
  22. Norde, W., and Anusiem, A., 1992, Adsorption, desorption and re-adsorption of proteins on solid surfaces, Colloids Surf. 66:73–80.CrossRefGoogle Scholar
  23. Norde, W., MacRitchie, F., Nowicka, G., and Lyklema, J., 1986, Protein adsorption at solid-liquid interfaces: Reversibility and conformation aspects, J. Colloid Interface Sci. 112:447–456.CrossRefGoogle Scholar
  24. Parks, G. A., 1965, The isoelectric points of solid oxides, solid hydroxides, and aqueous hydroxo complex systems, Chem. Rev. 65:177–198.CrossRefGoogle Scholar
  25. Rinella, J. V. Jr., White, J. L., and Hem, S. L., 1995, Effect of anions on model aluminum adjuvant containing vaccines, J. Colloid Interface Sci. (in press).Google Scholar
  26. Ross, S. D., 1974, Phosphates and other oxy-anions of group V, in: The Infrared Spectra of Minerals (V. C. Farmer, ed.), Mineralogical Society, London, p. 400.Google Scholar
  27. Seeber, S. J., White, J. L., and Hem, S. L., 1991a, Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid, J. Parenteral Sci. Tech. 45:156–159.Google Scholar
  28. Seeber, S. J., White, J. L., and Hem, S. L., 1991b, Predicting the adsorption of proteins by aluminum-containing adjuvants, Vaccine 9:201–203.PubMedCrossRefGoogle Scholar
  29. Serna, C. J., White, J. L., and Hem, S. L., 1977, Anion-aluminum hydroxide gel interactions, Soil Sci. Soc. Am. 741:1009–1013.CrossRefGoogle Scholar
  30. Shirodkar, S., Hutchinson, R. L., Perry, D. L., White, J. L., and Hem, S. L., 1990, Aluminum compounds used as adjuvants in vaccines, Pharm. Res. 2:1282–1288.CrossRefGoogle Scholar
  31. Souza Santos, P., Vallejo-Friere, A., Parsons, J., and Watson, J. H. L., 1958, The structure of Schmidt’s aluminum hydroxide gel, Experientia 14:318–320.PubMedCrossRefGoogle Scholar
  32. Srinivasan, R., and Ruckenstein, E., 1980, Role of physical forces in hydrophobic interaction chromatography, Sep. Purif. Methods 9:267–370.CrossRefGoogle Scholar
  33. Tettenhorst, R., and Hofmann, D. A., 1980, Crystal chemistry of boehmite, Clays Clay Miner. 28:373–380.CrossRefGoogle Scholar
  34. Van der Marel, H. W., and Beutelspacher, H., 1976, Atlas of Infrared Spectroscopy of Clay Minerals and Their Admixtures, Elsevier, Amsterdam, pp. 194, 228.Google Scholar
  35. Warren, H. S., and Chedid, L. A., 1988, Future prospects for vaccine adjuvants, CRC Crit. Rev. Immunol. 8:83–101.Google Scholar
  36. Warren, H. S., Vogel, F. R., and Chedid, L. A., 1986, Current status of immunological adjuvants, Annu. Rev. Immunol. 4:369–388.PubMedCrossRefGoogle Scholar
  37. White, J. L., and Hem, S. L., 1975, Role of carbonate in aluminum hydroxide gel established by Raman and infrared analysis, J. Pharm. Sci. 64:468–469.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Stanley L. Hem
    • 1
  • Joe L. White
    • 2
  1. 1.Department of Industrial and Physical PharmacyPurdue UniversityWest LafayetteUSA
  2. 2.Department of AgronomyPurdue UniversityWest LafayetteUSA

Personalised recommendations